IL-17A as a Key Mediator of Pulmonary-Intestinal Immune Interactions in a Mouse Model of Asthma and Colitis
Chengyong Wu,1 Xuxu Hu,1 Zhongyuan Mo,1 Yan Meng,1 Yingying Du,1 Yunyu Duan,1 Zaopin Zeng,1 Jiahui Shan,1 Juan Li,1 Nali Zhang,2 Youfeng Ma,2 Huaqi Wang,3 Chi Liu,4 Guojun Zhang,3 Paul S Foster,5 Huisha Xu,1 Fuguang Li,1,* Ming Yang1,2,6,* 1Department of Microbiology and Immu...
Saved in:
Main Authors: | Wu C, Hu X, Mo Z, Meng Y, Du Y, Duan Y, Zeng Z, Shan J, Li J, Zhang N, Ma Y, Wang H, Liu C, Zhang G, Foster PS, Xu H, Li F, Yang M |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2025-06-01
|
Series: | Journal of Inflammation Research |
Subjects: | |
Online Access: | https://www.dovepress.com/il-17a-as-a-key-mediator-of-pulmonary-intestinal-immune-interactions-i-peer-reviewed-fulltext-article-JIR |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Features of interleukin-17 and interleukin-23 expression in patients with inflammatory bowel diseases
by: Yu.M. Stepanov, et al.
Published: (2025-03-01) -
Cellular Heterogeneity and IL-17 Pathway Dynamics Reveal Insights into the Transition from Ulcerative Colitis to Colorectal Cancer Through scRNA-Seq Analysis
by: Li Y, et al.
Published: (2025-05-01) -
Immune changes at the injured sites in oxazolone-induced ulcerous colitis: Influence of ozone therapy
by: E. V. Davydova, et al.
Published: (2022-04-01) -
NEW POSSIBILITIES OF PHARMACOTHERAPY FOR IMMUNOINFLAMMATORY RHEUMATIC DISEASES: A FOCUS ON INHIBITORS OF INTERLEUKIN-17
by: E. L. Nasonov
Published: (2017-03-01) -
IL-17A, IL-17F and IL-23 in patients with rheumatoid arthritis
by: Natalia A. Lapkina, et al.
Published: (2024-09-01)